Search results
- 22.45Add to watchlist-0.00 (-0.00%)At close: Tue. Jul 16, 2024 3:57 PM EDT · Delayed Quote (USD) · Market closed
- Open22.39High22.52Low22.35
- Mkt Cap34.66BP/E (TTM)3.38Div & Yield1.28 & 5.68%
- Prev. Close22.4552 Wk. Low18.3852 Wk. High24.44
Related stocks
About 25 percent of adults with ALL have a subtype called “Ph-positive ALL” (also known as “Ph+ ALL” or “Philadelphia chromosome-positive ALL”). The leukemia cells of these patients have the Philadelphia chromosome, which is formed by a translocation between parts of chromosomes 9 and 22.
Find the latest The Allstate Corporation (ALL-PH) stock quote, history, news and other vital information to help you with your stock trading and investing.
Jun 22, 2022 · The Philadelphia chromosome (Ph) was the first cytogenetic abnormality associated with a human cancer, chronic myeloid leukemia (CML). 1 The rearrangement between chromosome 9 and chromosome 22,...
Nov 9, 2017 · Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL), also referred to as BCR-ABL1–like ALL, is a high-risk subset with a gene expression profile that shares significant overlap with that of Ph-positive (Ph +) ALL and is suggestive of activated kinase signaling.
- Sarah K. Tasian, Sarah K. Tasian, Mignon L. Loh, Mignon L. Loh, Stephen P. Hunger, Stephen P. Hunger
- 2017
Dec 9, 2022 · The optimal tyrosine kinase inhibitor. In newly diagnosed Ph+ ALL, the dominant clone is highly sensitive to all BCR-ABL1–targeted TKIs in combination with corticosteroids with CR rates 90% to 100% regardless of the generation of TKI used.
The Philadelphia chromosome (Ph), t(9;22), is seen in about 20 % to 30 % of adults diagnosed with acute lymphoblastic leukemia (ALL). It has been associated with poorer prognosis compared with Ph-negative ALL.
Jan 10, 2022 · If Philadelphia chromosomes aren’t present, the disease is known as Ph-negative (Ph-) ALL. Determining which type of ALL you have can help a doctor determine your prognosis and the best ...
